Prenetics’ IM8 Health Elevates Industry: Bright Minds Unite
Prenetics’ IM8 Health recently made waves in the health industry by announcing the addition of two distinguished clinical experts to its revered Scientific Advisory Board (SAB). The inclusion of Dr. Jeremy London and Dr. Amy Shah not only enhances the board’s prestige but also reaffirms IM8’s commitment to pioneering advancements in the supplements market.
IM8 Health, co-founded by David Beckham, is recognized for its dedication to combining cutting-edge science with nature’s most potent ingredients. The inclusion of Dr. London, a board-certified cardiothoracic surgeon specializing in preventive cardiovascular health, emphasizes the brand’s focus on heart health. Meanwhile, Dr. Shah’s expertise in gut health and hormonal balance promises to steer IM8 towards new wellness solutions, reflecting the brand’s comprehensive approach to health management.
A Legacy of Expertise
The move underscores IM8’s tradition of engaging world-class intellects, enhancing its credibility in scientific innovation. According to Fitt Insider, since its inception, the SAB has included prestigious members from acclaimed institutions such as Mayo Clinic, Cedars-Sinai, NASA, and Yale University.
Uniting Pioneers in Health
Dr. Dawn Mussallem, a Mayo Clinic integrative oncologist, and Dr. Jim Green, former chief scientist at NASA, are just some of the luminaries whose extensive expertise and groundbreaking research have shaped the direction of IM8.
Trailblazing Innovations
IM8 continues to lead the supplement industry with products like the Daily Ultimate Essentials, a clinically-validated all-in-one supplement designed to replace numerous daily vitamins. This product stands as a testament to the SAB’s role in guiding IM8’s product development through rigorous scientific trials and certifications.
Paving the Way Forward
The global supplements market is on a significant growth trajectory, with consumer demand on the rise for scientifically-backed products. IM8 Health remains at the forefront of this dynamic industry, poised to set new standards. The SAB’s strategic guidance is crucial in maintaining IM8’s commitment to quality, transparency, and efficacy.
In a rapidly expanding health market, IM8 Health continues to embody innovation and reliability, ensuring that consumers have access to products that are as effective as they are trustworthy.